Erpolat, O. P. Et Al. 2014. Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.35, no.1 , 62-66.

Erpolat, O. P., Alco, G., Caglar, H. B., Igdem, S., Saran, A., Dagoglu, N., ... Aslay, I.(2014). Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study. EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.35, no.1, 62-66.

Erpolat, O. Et Al. "Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study," EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.35, no.1, 62-66, 2014

Erpolat, O. P. Et Al. "Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study." EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.35, no.1, pp.62-66, 2014

Erpolat, O. P. Et Al. (2014) . "Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study." EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , vol.35, no.1, pp.62-66.

@article{article, author={O. P. Erpolat Et Al. }, title={Comparison of hematologic toxicity between 3DCRT and IMRT planning in cervical cancer patients after concurrent chemoradiotherapy: a national multi-center study}, journal={EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY}, year=2014, pages={62-66} }